A detailed history of Banque Transatlantique Sa transactions in Astrazeneca PLC stock. As of the latest transaction made, Banque Transatlantique Sa holds 402 shares of AZN stock, worth $30,069. This represents 0.0% of its overall portfolio holdings.

Number of Shares
402
Holding current value
$30,069
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$63.2 - $79.58 $25,406 - $31,991
402 New
402 $26.2 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $232B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Banque Transatlantique Sa Portfolio

Follow Banque Transatlantique Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Transatlantique Sa, based on Form 13F filings with the SEC.

News

Stay updated on Banque Transatlantique Sa with notifications on news.